NCT06091995View on ClinicalTrials.gov

Use of Belatacept to Delay Tacrolimus Initiation in Kidney Transplant Patients with Delayed Graft Function

Active, not recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

August 22, 2022

Primary Completion Date

August 22, 2025

Study Completion Date

August 22, 2025

Conditions
Use of Belatacept in Kidney Transplant Patients
Interventions
BEHAVIORAL

impact of administering one dose of belatacept on Estimated Glomerular Filtration Rate(eGFR)

Evaluate the clinical impact of administering one dose of belatacept on eGFR at one-year post-transplant, patient and graft survival outcomes, graft rejection, and incidences of BK virus, EBV and CMV infections.

Trial Locations (1)

75203

Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER